Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
NEW YORK, NY–(The News File Corporation – January 14, 2025) – why: Rosen Law Firm, a global investor rights law firm, has filed a lawsuit against Cassava Science Inc. (NASDAQ: NASDAQ: ) between February 7, 2024 and November 24, 2024, both dates inclusive (the “Class Period”), the relevant February 10, 2025 Lead Plaintiff Deadline.
So what? If you purchase cassava securities during the class period, you may receive compensation through a contingency payment arrangement without paying any out-of-pocket fees or expenses.
What to do next: To join the Cassava class action, go to https://rosenlegal.com/submit-form/?case_id=22374 or call Phillip Kim, Esq. Toll free at 866-767-3653 or email case@rosenlegal.com for class action information. A class action lawsuit has already been filed. If you want to serve as lead plaintiff, you must move the court After February 10, 2025. A lead plaintiff is a representative party who conducts litigation on behalf of other class members.
Why the Rose Rule? We encourage investors to select a qualified advisor with a track record of success in a leadership role. Oftentimes, the organizations that issue the ads don’t have comparable experience, resources, or any meaningful peer recognition. Most of these firms do not litigate class actions but are intermediaries who refer clients or litigate cases with law firms. Be wise when choosing advice. The Rosen Law Firm represents investors worldwide, focusing its practice on securities class actions and shareholder origination litigation. Rosen Law Firm won the largest securities class action against a Chinese company at the time. Rosen Law Firm is rated Class 1 by ISS Securities Action (WA:) Services in 2017 for the securities division of the action settlement number. The firm has been ranked in the top 4 every year since 2013 and has returned hundreds of millions of dollars to investors. In the year In 2019 alone, the company raised over $438 million for investors. In the year In 2020, founding partner Lawrence Rosen was named a Titan of the Plaintiffs Bar by Law360. Many of the firm’s lawyers are accredited by Laudragon and Super Lawyers.
Details of the case:- According to the suit, the class-action defendants created a false impression that they had reliable information about the promise and development of the cassava drug, as well as minimizing the risk of the drug’s failure. However, in reality, confidence in Simufilam, cassava’s lead drug candidate, and riding on the statistically insignificant data from the Phase 2 study fell short of the reality of Simufilam’s potential. Even when trying to treat only mild to moderate cases, cassava has not been shown to halt the progression of Alzheimer’s disease. Investors were harmed, the suit says, when the correct listings entered the market.
To join the cassava class action, call https://rosenlegal.com/submit-form/?case_id=22374 Phillip Kim, Esq. Toll free at 866-767-3653 or email case@rosenlegal.com for class action information.
No class confirmed. Unless a unit is confirmed, you will not be represented by a consultant unless you have booked one. You can choose the advice of your choice. You can also remain a member of a class you are not in and do nothing at this point. An investor’s ability to participate in any future recovery is not dependent on serving as a lead plaintiff.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm or on Facebook (NASDAQ): https://www.linkedin. com/company/ /www.facebook.com/rosenlawfirm.
Notice of attorney. Previous results do not guarantee the same result.
————————————-
To view the source of this press release, please visit https://www.newsfilecorp.com/release/237259.
